Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the Trials: Real-World Insights into Tezepelumab Efficacy.

American journal of respiratory and critical care medicine·2026
Same author

Safe blood, strong nation - The journey of India's blood transfusion services: Under Ministry of Health and Family Welfare, Government of India.

Asian journal of transfusion science·2026
Same author

Navigating the uncharted: AI-driven advances in protein structure, dynamics, interactions and ligand interactions for understudied families.

BioData mining·2026
Same author

Impact of education protocols and physiotherapeutic management in improving pain, symptoms, activities of daily living, and quality of life in patients with knee osteoarthritis: A systematic review and meta-analysis.

The Knee·2026
Same author

Letter to the editor regarding "Telerehabilitation vs face-to-face computer-based cognitive training in stroke patients: a randomized controlled trial".

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Dynamic system reliability under external shocks and internal markovian degradation.

Scientific reports·2026
Same journal

Correction: Reis et al. Bioinks Enriched with ECM Components Obtained by Supercritical Extraction. <i>Biomolecules</i> 2022, <i>12</i>, 394.

Biomolecules·2026
Same journal

Correction: Kim, K.-H.; Yoo, B.C. Gintonin as a Lysophosphatidic Acid-Enriched GPCR Ligand System: Molecular Architecture and Receptor Pharmacology in <i>Panax ginseng</i>. <i>Biomolecules</i> 2026, <i>16</i>, 465.

Biomolecules·2026
Same journal

Correction: Bastyte et al. The Association of Vitamin D Receptor Gene Polymorphisms with Vitamin D, Total IgE, and Blood Eosinophils in Patients with Atopy. <i>Biomolecules</i> 2024, <i>14</i>, 212.

Biomolecules·2026
Same journal

AtHSPR Plays a Positive Role in Arabidopsis Resistance Against <i>Pseudomonas syringae</i> pv. <i>tomato</i> DC3000 by Interacting with TOP1.

Biomolecules·2026
Same journal

CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion.

Biomolecules·2026
Same journal

Integrated Immune-Gut Profiling Identifies an Exploratory Pediatric Inflammatory Intestinal Profile Associated with Food-Specific IgG Reactivity.

Biomolecules·2026
See all related articles

Related Experiment Video

Updated: Jul 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

An Update on S100A16 in Human Cancer.

Suyog Basnet1, Evan Michael Vallenari2, Urusha Maharjan3,4

  • 1Curida Diatec, 1364 Oslo, Norway.

Biomolecules
|July 29, 2023
PubMed
Summary
This summary is machine-generated.

S100A16 protein is found in many human tissues and is linked to cancer development, affecting cell growth and spread. Its expression levels may help predict cancer outcomes.

Keywords:
EMTS100biomarkersinvasionprognosisproliferation

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • S100A16 is a protein in the S100 family, expressed across various human tissues, particularly those rich in epithelial cells.
  • Differential expression of S100A16 mRNA and protein is observed in most human cancers, suggesting a role in tumorigenesis.

Purpose of the Study:

  • To review the expression patterns of S100A16 in human cancers.
  • To identify S100A16's molecular partners and functional roles in cancer.
  • To explore the prognostic value of S100A16 expression in various cancer types.

Main Methods:

  • Literature review of studies on S100A16 expression, function, and prognostic significance in human cancers.
  • Analysis of reported molecular interactions and signaling pathways regulated by S100A16.
  • Synthesis of findings related to S100A16's role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).

Main Results:

  • S100A16 is implicated in key tumorigenesis processes, including cell proliferation, differentiation, migration, invasion, and EMT.
  • S100A16 influences cancer progression through interactions with pathways like PI3K-AKT, p53, and EMT-related proteins (E-cadherin, Vimentin).
  • Evidence suggests S100A16 can act as both a tumor promoter and suppressor, with its expression potentially indicating patient prognosis.

Conclusions:

  • S100A16 plays a multifaceted role in human cancers, influencing critical cellular processes and signaling pathways.
  • The expression profile and functional involvement of S100A16 highlight its potential as a biomarker for cancer prognosis.
  • Further research into S100A16's complex roles could lead to novel therapeutic strategies in oncology.